We are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
$14.00 - $16.00
May 9, 2019
MORGAN STANLEY & CO. LLC, PIPER JAFFRAY & CO.
To view the prospectus for NextCure IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277